Yew Bio-Pharm Group, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 27.307 million compared to USD 27.883 million a year ago. Operating income was USD 2.568 million compared to USD 1.011 million a year ago. Net income was USD 1.464 million compared to USD 985,506 a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.